Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes

J Clin Lipidol. 2016 Jul-Aug;10(4):808-815. doi: 10.1016/j.jacl.2016.03.001. Epub 2016 Mar 8.

Abstract

Background: Apolipoprotein A-II (apoA-II) is the second most abundant protein in high-density lipoprotein particles. However, it exists in plasma in multiple forms. The effect of diabetes on apoA-II proteoforms is not known.

Objective: Our objective was to characterize plasma apoA-II proteoforms in participants with and without type 2 diabetes.

Methods: Using a novel mass spectrometric immunoassay, the relative abundance of apoA-II proteoforms was examined in plasma of 30 participants with type 2 diabetes and 25 participants without diabetes.

Results: Six apoA-II proteoforms (monomer, truncated TQ monomer, truncated Q monomer, dimer, truncated Q dimer, and truncated 2Qs dimer) and their oxidized proteoforms were identified. The ratios of oxidized monomer and all oxidized proteoforms to the native apoA-II were significantly greater in the diabetic group (P = .004 and P = .005, respectively) compared with the nondiabetic group.

Conclusion: The relative abundance of oxidized apoA-II is significantly increased in type 2 diabetes.

Keywords: Apolipoprotein A-II; Diabetes; Mass spectrometry; Oxidations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoprotein A-II / blood*
  • Apolipoprotein A-II / metabolism*
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / metabolism*
  • Female
  • Humans
  • Male
  • Protein Processing, Post-Translational*

Substances

  • Apolipoprotein A-II